(Q42590864)

3 November 2017

Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid (English)

1 reference

3 November 2017

0 references

0 references

Ching LM

1

1 reference

3 November 2017

Xu ZF

2

1 reference

3 November 2017

Gummer BH

3

1 reference

3 November 2017

Palmer BD

4

1 reference

3 November 2017

Joseph WR

5

1 reference

3 November 2017

Baguley BC

6

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 August 1995

1 reference

British Journal of Cancer

3 November 2017

1 reference

3 November 2017

72

1 reference

3 November 2017

339-343

1 reference

3 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.335

3 November 2017

0 references

cites work

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Thalidomide--the need for a new clinical evaluation of an old drug.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Comparison of in vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell lines.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancer

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

Blood flow failure as a major determinant in the antitumor action of flavone acetic acid.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033997

28 May 2018

1 reference

12 December 2020

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

12 December 2020

Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial

1 reference

12 December 2020

Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours

1 reference

12 December 2020

Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study.

1 reference

12 December 2020

PREPARATION OF ONE OF THE OPTICAL ANTIPODES OF 2-PHTHALIMIDOGLUTARIMIDE

1 reference

12 December 2020

Toxicity and Teratogenicity of Optical Isomers of Thalidomide

1 reference

12 December 2020

Comparison of the effects of flavone acetic acid, fostriecin, homoharringtonine and tumour necrosis factor alpha on colon 38 tumours in mice

1 reference

12 December 2020

Light-induced breakdown of flavone acetic acid and xanthenone analogues in solution

1 reference

12 December 2020

Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown

1 reference

12 December 2020

Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid

1 reference

12 December 2020

Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.335

1 reference

3 November 2017

1 reference

3 November 2017

1 reference